Secil Koseoglu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Secil Koseoglu

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Blood|April 6, 2026

Platelet Drp1 phosphorylation provides a platform for immune-based platelet function testingDavid A Barrios, Shihui Guo, Matthew Powers, et al.

Cancer Immunology Research|November 21, 2022

CD73 Inhibits cGAS-STING and Cooperates with CD39 to Promote Pancreatic CancerCélia Jacoberger-Foissac, Isabelle Cousineau, Yacine Bareche, et al.

Immunohorizons|May 23, 2023

SRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor PropertiesMichael C Warren, Stephan Matissek, Matthew Rausch, et al.

Molecular Cancer Therapeutics|August 14, 2020

Preclinical Antitumor Activity and Biodistribution of a Novel Anti-GCC Antibody-Drug Conjugate in Patient-derived XenograftsAdnan O Abu-Yousif, Donna Cvet, Melissa Gallery, et al.

Pageof 2

Search research articles

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Blood|April 6, 2026

Platelet Drp1 phosphorylation provides a platform for immune-based platelet function testingDavid A Barrios, Shihui Guo, Matthew Powers, et al.

Cancer Immunology Research|November 21, 2022

CD73 Inhibits cGAS-STING and Cooperates with CD39 to Promote Pancreatic CancerCélia Jacoberger-Foissac, Isabelle Cousineau, Yacine Bareche, et al.

Immunohorizons|May 23, 2023

SRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor PropertiesMichael C Warren, Stephan Matissek, Matthew Rausch, et al.

Molecular Cancer Therapeutics|August 14, 2020

Preclinical Antitumor Activity and Biodistribution of a Novel Anti-GCC Antibody-Drug Conjugate in Patient-derived XenograftsAdnan O Abu-Yousif, Donna Cvet, Melissa Gallery, et al.

Pageof 2